Nipro newsletter April 2026
tjoapck banner – feb 2026
Carterra 23/09/25
LB Bohle – 10.06.2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Merxin March 2026
Chemspec Feb 2026
the bridge – website ad 28/01/2026
Terumo 05/01
Nipro April 2026
SAE Media – Pre-filled syringes West Coast 19/11/25

IP Audits: A Health Check for your Intellectual Property

For most biotechnology and pharmaceutical companies, Intellectual Property (IP) is the solid foundation on which the business is built. But when was the last time that you reviewed your IP assets? Elaine Eggington at IP Pragmatics discusses how an IP audit is a valuable tool to look at each potential area of IP, including patent s, trade marks, copyright, branding and confidential know-how (trade secrets) to ensure that they are being identified and managed correctly.
 

https://international-pharma.com/wp-content/uploads/2012/12/2-IP-Audits-A-Health-Check-for-your-Intellectual-Property.pdf
SMI London
Biopharma group march 2026
Interpack Staubli March 2026
Silgan March 2026
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Aptar – 08/01/2026
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025